Practice guidelines for managing extrahepatic biliary tract cancers
- Author:
Hyung Sun KIM
1
;
Mee Joo KANG
;
Jingu KANG
;
Kyubo KIM
;
Bohyun KIM
;
Seong-Hun KIM
;
Soo Jin KIM
;
Yong-Il KIM
;
Joo Young KIM
;
Jin Sil KIM
;
Haeryoung KIM
;
Hyo Jung KIM
;
Ji Hae NAHM
;
Won Suk PARK
;
Eunkyu PARK
;
Joo Kyung PARK
;
Jin Myung PARK
;
Byeong Jun SONG
;
Yong Chan SHIN
;
Keun Soo AHN
;
Sang Myung WOO
;
Jeong Il YU
;
Changhoon YOO
;
Kyoungbun LEE
;
Dong Ho LEE
;
Myung Ah LEE
;
Seung Eun LEE
;
Ik Jae LEE
;
Huisong LEE
;
Jung Ho IM
;
Kee-Taek JANG
;
Hye Young JANG
;
Sun-Young JUN
;
Hong Jae CHON
;
Min Kyu JUNG
;
Yong Eun CHUNG
;
Jae Uk CHONG
;
Eunae CHO
;
Eui Kyu CHIE
;
Sae Byeol CHOI
;
Seo-Yeon CHOI
;
Seong Ji CHOI
;
Joon Young CHOI
;
Hye-Jeong CHOI
;
Seung-Mo HONG
;
Ji Hyung HONG
;
Tae Ho HONG
;
Shin Hye HWANG
;
In Gyu HWANG
;
Joon Seong PARK
Author Information
- Publication Type:Original Article
- From: Annals of Hepato-Biliary-Pancreatic Surgery 2024;28(2):161-202
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:s/Aims: Reported incidence of extrahepatic bile duct cancer is higher in Asians than in Western populations. Korea, in particular, is one of the countries with the highest incidence rates of extrahepatic bile duct cancer in the world. Although research and innovative therapeutic modalities for extrahepatic bile duct cancer are emerging, clinical guidelines are currently unavailable in Korea. The Korean Society of Hepato-Biliary-Pancreatic Surgery in collaboration with related societies (Korean Pancreatic and Biliary Surgery Society, Korean Society of Abdominal Radiology, Korean Society of Medical Oncology, Korean Society of Radiation Oncology, Korean Society of Pathologists, and Korean Society of Nuclear Medicine) decided to establish clinical guideline for extrahepatic bile duct cancer in June 2021.
Methods:Contents of the guidelines were developed through subgroup meetings for each key question and a preliminary draft was finalized through a Clinical Guidelines Committee workshop.
Results:In November 2021, the finalized draft was presented for public scrutiny during a formal hearing.
Conclusions:The extrahepatic guideline committee believed that this guideline could be helpful in the treatment of patients.
